Abstract
Drug-induced neutropenia is characterized by a sharp decrease in the absolute neutrophil count (ANC) to <500/mm3; agranulocytosis is said to be present once the granulocyte count reaches zero. Although associated with a large variety of drugs, this adverse effect is rare, occurring in 2.4–15.4 cases per million courses of therapy [1]. Because of its efficacy and relative safety, ceftriaxone is commonly used for treating a broad range of serious infections [2]. In this report, we describe a patient who developed agranulocytosis during treatment with ceftriaxone and recovered after treatment was changed to cefepime, and we review previously reported cases of ceftriaxone-induced agranulocytosis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
